Mark E. Saad - 21 Feb 2025 Form 4 Insider Report for Axsome Therapeutics, Inc. (AXSM)

Role
Director
Signature
/s/ Nick Pizzie, Attorney-in-Fact
Issuer symbol
AXSM
Transactions as of
21 Feb 2025
Net transactions value
$0
Form type
4
Filing time
25 Feb 2025, 19:59:08 UTC
Previous filing
11 Sep 2024
Next filing
10 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXSM Stock Option (Right to Buy) Award $0 +1,494 $0.000000 1,494 21 Feb 2025 Common Stock 1,494 $137.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 1,494 options elected to be received in lieu of cash compensation earned in 2024. All of such options are immediately exercisable.